# Mis-splicing drives loss of function of p53E224D point mutation

**Authors:** Ian C. Lock, Nathan H. Leisenring, Warren Floyd, Eric S. Xu, Lixia Luo, Yan Ma, Erin C. Mansell, Diana M. Cardona, Chang-Lung Lee, David G. Kirsch

PMC · DOI: 10.1371/journal.pone.0318856 · PLOS One · 2025-03-05

## TL;DR

A specific p53 mutation leads to mis-splicing and loss of function, contributing to tumor development.

## Contribution

A novel mouse model reveals that p53E221D mutation causes mis-splicing and loss of function despite appearing functional in assays.

## Key findings

- p53E221D RNA is mis-spliced, leading to nonsense-mediated decay.
- Mice with p53E221D mutation show increased tumor penetrance and reduced lifespan.
- Human p53E224D mutation also causes splice variation and loss of function.

## Abstract

The tumor suppressor p53 (Trp53), also known as p53, is the most commonly mutated gene in cancer. Canonical p53 DNA damage response pathways are well characterized and classically thought to underlie the tumor suppressive effect of p53. Challenging this dogma, mouse models have revealed that p53-driven apoptosis and cell cycle arrest are dispensable for tumor suppression. Here, we investigated the inverse context of a p53 mutation predicted to drive the expression of canonical targets but is detected in human cancer.

We established a novel mouse model with a single base pair mutation (GAG>GAT, p53E221D) in the DNA-Binding domain that has wild-type function in screening assays, but is paradoxically found in human cancer in Li-Fraumeni syndrome. Using mouse p53E221D and the analogous human p53E224D mutants, we evaluated expression, transcriptional activation, and tumor suppression in vitro and in vivo.

Expression of human p53E224D from cDNA translated to a fully functional p53 protein. However, p53E221D/E221D RNA transcribed from the endogenous locus is mis-spliced resulting in nonsense-mediated decay. Moreover, fibroblasts derived from p53E221D/E221D mice do not express a detectable protein product. Mice homozygous for p53E221D exhibited increased tumor penetrance and decreased life expectancy compared to p53WT/WT animals.

Mouse p53E221D and human p53E224D mutations lead to splice variation and a biologically relevant p53 loss of function in vitro and in vivo.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], TP53 (tumor protein p53) [NCBI Gene 7157]
- **Proteins:** TP53 (tumor protein p53)
- **Diseases:** Li-Fraumeni syndrome (MONDO:0018875), cancer (MONDO:0004992)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}
- **Diseases:** cancer (MESH:D009369), Li-Fraumeni syndrome (MESH:D016864)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** p53E221D, E221D, GAG>GAT, E224D

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11882087/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11882087/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC11882087/full.md

---
Source: https://tomesphere.com/paper/PMC11882087